Needham lifts target for iRhythm Technologies stock to USD 194.00
Published on 10/15/2026 at 20:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and coming results
- Needham set a USD 194.00 target for iRhythm Technologies on October 5, 2026.
- Second-quarter revenue reached USD 224.17 million for the period ended June 30, 2026.
- iRhythm Technologies stock was at EUR 95.25 at Lang & Schwarz on October 15, 2026 at 8:40 p.m. CEST.
- The third-quarter earnings call is scheduled for November 5, 2026.
Needham raised its price target for iRhythm Technologies from USD 192.00 to USD 194.00 on October 5, 2026, according to MarketBeat. Against the USD 106.82 Nasdaq price at 2:46 p.m. ET on October 15, 2026, the target stands 81.61 percent above the home-market price. iRhythm Technologies stock was at EUR 95.25 at Lang & Schwarz on October 15, 2026 at 8:40 p.m. CEST.
Revenue reached USD 224.17 million
iRhythm reported USD 224.17 million in revenue for the second quarter ended June 30, 2026. The company recorded an operating loss of USD 2.54 million and a net loss attributable to common shareholders of USD 0.38 million in that period. The figures show a narrower loss than in the first quarter, when revenue was USD 199.39 million, operating loss was USD 16.19 million and net loss was USD 13.93 million.
Cash from operating activities was USD 51.08 million in the second quarter, compared with an operating cash outflow of USD 26.17 million in the first quarter. The reported second-quarter figures are also carried by Investing.com.
Price sits near the yearly low
The Nasdaq price of USD 106.82 was above the 52-week low of USD 100.70 and below the high of USD 212.00 on October 15, 2026. The session volume was 565,557 shares, against an average volume of 170,257 shares. The market capitalization stood at USD 3.5 billion, while the price-to-earnings ratio was negative 248.31.
November 5 brings the next report
iRhythm is scheduled to hold its third-quarter earnings call on November 5, 2026, when it plans to provide updated 2026 financial guidance that includes VitalConnect, according to StockTitan. The date gives investors a defined checkpoint for revenue expectations, operating losses and the financial contribution from the acquired business.
Euro quote after hours
The euro quotation places the stock at EUR 95.25 at Lang & Schwarz on October 15, 2026 at 8:40 p.m. CEST. The Nasdaq session price was USD 106.82 at 2:46 p.m. ET on the same date, keeping the two venue quotations clearly separated.
The further course of trading is shown by the continuously updated real-time quote of iRhythm Technologies stock.
iRhythm Technologies market data
- Company: iRhythm Technologies, Inc.
- ISIN: US4500561067
- Ticker: IRTC
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 8:40 p.m. CEST): EUR 95.25
- Market capitalization: USD 3.5 billion (as of October 15, 2026)
- 52-week range: USD 100.70-212.00 (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: November 5, 2026
Market context: Market report Nasdaq Composite.
